BI-2852 free base · Synonyms: BI 2852 · BI2852
BI-2852 is a KRAS inhibitor.
For research use only. Not for human or veterinary use.
BI-2852 structure
CAS No.: 2375482-51-0
Pack sizes & pricing
Description
BI-2852 is a KRAS inhibitor for the switch I/II pocket (SI/II-pocket) by structure-based drug design with nanomolar affinity.
Biological activity
BI-2852 is a KRAS inhibitor for the switch I/II pocket (SI/II-pocket) by structure-based drug design with nanomolar affinity. BI-2852 is mechanistically distinct from covalent KRASG12C inhibitor (binds to switch II pocket) and binds ten-fold more strongly to active KRASG12D versus KRASwt (740 nM vs 7.5 μM). BI-2852 blocks GEF, GAP, and effector interactions with KRAS, leading to inhibition of downstream signaling and an antiproliferative effect in KRAS mutant cells.
Identifiers
- SMILES
-
OC(C=C1)=CC([C@@H](C2=C(CNCC3=CC4=C(C=CN4CC5=CN(C)C=N5)C=C3)NC6=CC=CC=C62)N7)=C1C7=O - InChIKey
-
JYEQLXOWWLNVDX-PMERELPUSA-N
Specifications
- MW (average)
- 516.5930
- Formula
- C31H28N6O2
- CAS No.
- 2375482-51-0
- Physical state
- Solid
- Color
- Off-white to light yellow
- Shipping
- Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
- Storage
- Powder -20℃ 2 years; In solvent -20℃ 1 month;
Solubility
Soluble in DMSO
- In vitro
- DMSO : 55 mg/mL
Documents
References
Same target
Search Ras- BP-01564 pan-KRAS degrader 1 free base · >98%
- BP-01922 ARS-1630 free base · >98%
- BP-01938 Clifutinib free base · >98%
- BP-02004 K-Ras G12C-IN-4 free base · >98%
- BP-02013A GDC-6036 other · >98%
- BP-02017 ARS-1323-alkyne free base · >98%
- BP-02024 RMC-0331 free base · >98%
- BP-02028 DCC-3116 free base · >98%
Same research area
Search Cancer- BP-00006 SLF Exclusive free base · >98%
- BP-00008 NSC-339004 free base · >98%
- BP-00019 SLF-amido-C2-COOH free base · >98%
- BP-00020 PT262 free base · >98%
- BP-00022 Inolitazone free base · >98%
- BP-00024 KX2-361 free base · >98%
- BP-00030 EML4-ALK kinase inhibitor 1 free base · >98%
- BP-00037 SB 328437 free base · >98%